Global Anesthesia Reversal Drugs Market Report By Drug (Neuromuscular Blockade Reversing Agents, Opioid Antagonists, Sedative Reversal Drugs, Coagulant Reversal Drugs, Analeptic Agents, Others), By Route of Administration (Intravenous, Intramuscular, Nasal, Oral, Others), By End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Anesthesia Reversal Drugs Market Report
Brand: Value Market Research
SKU: Pharmaceuticals
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212365

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Anesthesia Reversal Drugs Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Anaesthesia Reversal Drugs are a special class of drugs used to reverse the effects of anaesthesia, opioids and sedatives given during surgical procedures. The common routine performed after surgeries are the reversal of neuromuscular blockade in anaesthetic patients. The need for this reversal is to enable a patient to make critical decisions soon after his procedure. The various other advantages offered are reduction in turn overtime at the operation theatre and less staff overload in recovery rooms. The most used drugs are sugammadex, cysteine, naloxone, nalmefene, atipamezole and heparin and the choice depend on the surgical procedure.

Market Dynamics

The increased number of surgical procedures being carried out globally is the main driver for the growth of this market. Changing lifestyles and the need for patients to come out of anaesthesia as quickly as possible will boost the growth of this market. Overcrowded healthcare facilities and the need to discharge patients as soon as possible will augment the demand for anaesthesia reversal drugs. Increased awareness and enhanced research activities carried out to develop new formulations will boost the market. The demand for these drugs will grow at an alarming rate during the COVID-19 pandemic because of the number of patients admitted to ICUs. The major constraints hampering the growth of this market are higher costs associated with testing and restricted acceptance of new drugs.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of anesthesia reversal drugs.

Market Segmentation

The entire anesthesia reversal drugs market has been sub-categorized into drug, route of administration and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Drug

By Route of Administration

Intravenous
Intramuscular
Nasal
Oral
Others

By End-User

Hospitals
Ambulatory Surgery Centers
Specialty Clinics
Others

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for anesthesia reversal drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Anesthesia Reversal Drugs Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the anesthesia reversal drugs market include West-Ward Pharmaceuticals, Novalar Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Allergan plc, kaleo, Inc., ADAPT Pharma Inc. (Emergent BioSolutions Inc.), Merck & Co., Inc., Novartis AG, Troikaa Pharmaceuticals Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Anesthesia Reversal Drugs Market
       2.2. Global Anesthesia Reversal Drugs Market Snapshot

3 . ANESTHESIA REVERSAL DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Anesthesia Reversal Drugs Market
       3.3. Market Restraints of Anesthesia Reversal Drugs Market
       3.4. Opportunities of Anesthesia Reversal Drugs Market
       3.5. Trends of Anesthesia Reversal Drugs Market
       3.6. Porter’s Five Force Analysis of Anesthesia Reversal Drugs Market
       3.7. Anesthesia Reversal Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug
           3.7.2 Market Attractive Analysis by Route of Administration
           3.7.3 Market Attractive Analysis by End-User
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Anesthesia Reversal Drugs Value Chain Analysis
       4.2. Anesthesia Reversal Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Anesthesia Reversal Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Anesthesia Reversal Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Anesthesia Reversal Drugs Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Anesthesia Reversal Drugs Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Anesthesia Reversal Drugs Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Anesthesia Reversal Drugs Market

6 . GLOBAL ANESTHESIA REVERSAL DRUGS MARKET ANALYSIS BY DRUG
       6.1 Overview by Drug
       6.2 Global Anesthesia Reversal Drugs Market Analysis by Drug
       6.3 Market Analysis of Neuromuscular Blockade Reversing Agents by Regions
       6.4 Market Analysis of Opioid Antagonists by Regions
       6.6 Market Analysis of Sedative Reversal Drugs by Regions
       6.5 Market Analysis of Coagulant Reversal Drugs by Regions
       6.7 Market Analysis of Analeptic Agents by Regions
       6.8 Market Analysis of Others by Regions

7 . GLOBAL ANESTHESIA REVERSAL DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       7.1 Overview by Route of Administration
       7.2 Global Anesthesia Reversal Drugs Market Analysis by Route of Administration
       7.3 Market Analysis of Intravenous by Regions
       7.4 Market Analysis of Intramuscular by Regions
       7.5 Market Analysis of Nasal by Regions
       7.6 Market Analysis of Oral by Regions
       7.7 Market Analysis of Others by Regions

8 . GLOBAL ANESTHESIA REVERSAL DRUGS MARKET ANALYSIS BY END-USER
       8.1 Overview by End-User
       8.2 Global Anesthesia Reversal Drugs Market Analysis by End-User
       8.3 Market Analysis of Hospitals by Regions
       8.4 Market Analysis of Ambulatory Surgery Centers by Regions
       8.5 Market Analysis of Specialty Clinics by Regions
       8.6 Market Analysis of Others by Regions

9 . GLOBAL ANESTHESIA REVERSAL DRUGS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Anesthesia Reversal Drugs Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Anesthesia Reversal Drugs Market Estimate by Market Segment
           9.4.3. Europe Anesthesia Reversal Drugs Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Anesthesia Reversal Drugs Market Estimate by Market Segment
           9.5.3. Asia Pacific Anesthesia Reversal Drugs Market Estimate by Country
           9.5.4. China
          9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Anesthesia Reversal Drugs Market Estimate by Market Segment
           9.6.3. Latin America Anesthesia Reversal Drugs Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Anesthesia Reversal Drugs Market Estimate by Market Segment
           9.7.3. Middle East & Africa Anesthesia Reversal Drugs Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa

10 . COMPETITIVE LANDSCAPE OF THE ANESTHESIA REVERSAL DRUGS COMPANIES
       10.1. Anesthesia Reversal Drugs Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments

11 . COMPANY PROFILES OF ANESTHESIA REVERSAL DRUGS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. West-Ward Pharmaceuticals
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Novalar Pharmaceuticals, Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Allergan plc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. kaleo, Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. ADAPT Pharma Inc. (Emergent BioSolutions Inc.)
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Merck & Co., Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Novartis AG
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Troikaa Pharmaceuticals Ltd.
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments

*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "